Literature DB >> 10916272

Adrenocortical reserve and morphology in tuberculosis.

G A Prasad1, S K Sharma, A Mohan, N Gupta, S Bajaj, P K Saha, N K Misra, N P Kochupillai, J N Pande.   

Abstract

Ninety seven patients (63 males, mean age 31.8 years, SD 2.3) with various forms of tuberculosis were studied. All of them were HIV negative. Thirty normal control subjects (16 males, mean age 36.4 years, SD 1.8) were also studied. Fifty-eight of the 97 patients (59.8%) were malnourished (BMI < 18 kg/m2). The mean basal serum cortisol was lower in the TB group (n = 91) (351 nmol/1; SD 150) as compared to the normal control group (n = 8) (402 nmol/1; SD 93) but this difference did not attain statistical significance. Following administration of synthetic ACTH (cosyntropin), the 30 and 60 minutes mean serum cortisol values in the TB group were significantly lower as compared to the normal control group (p < 0.05). Forty five of the 91 patients (49.5%) who underwent the ACTH stimulation test had compromised adrenal reserve. Fourteen of the 86 patients (16.3%) in whom adrenal morphology was studied revealed adrenal gland enlargement on abdominal CT scan. ACTH stimulation was done in 12 of these 14 patients and eight of them had compromised adrenal reserve. Repeat ACTH stimulation done six months to one year after treatment in 13 patients revealed significantly increased 30 minutes (p < 0.05) and 60 minutes (p < 0.05) serum cortisol values. While nine of these 13 patients were negative responders before treatment, only three of them had evidence of compromised adrenal reserve after one year of antituberculosis treatment, (p < 0.05). Serum cortisol values in patients with drug-sensitive and drug-resistant tuberculosis did not differ significantly. Patients with drug-resistant tuberculosis had a higher prevalence of adrenal gland enlargement (7 of the 30) as compared to those with drug-sensitive tuberculosis (7 of the 56) (p = NS). Subclinical adrenal insufficiency is prevalent in a significant number of patients with both drug-sensitive and drug-resistant tuberculosis, and in some of these it is associated with adrenal gland enlargement. The compromised adrenal reserve and enlargement seem to reverse with therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10916272

Source DB:  PubMed          Journal:  Indian J Chest Dis Allied Sci        ISSN: 0377-9343


  7 in total

Review 1.  Endocrine and Metabolic Aspects of Tuberculosis.

Authors:  Christopher Vinnard; Emily A Blumberg
Journal:  Microbiol Spectr       Date:  2017-01

2.  ADRENAL HISTOPLASMOSIS: AN EASTERN INDIAN PERSPECTIVE.

Authors:  S S Agrawal; P P Chakraborty; A Sinha; A Maiti; M Chakraborty
Journal:  Acta Endocrinol (Buchar)       Date:  2022 Jan-Mar       Impact factor: 1.104

3.  Clinical Profile of Addison's Disease in a Tertiary Care Institute, Southern India - The Changing Landscape.

Authors:  Subbiah Sridhar; Karthik Balachandran; Roshan Nazirudeen; Vasanthiy Natarajan; Jayaraman Sangumani
Journal:  Indian J Endocrinol Metab       Date:  2022-04-27

4.  Functional adrenal insufficiency among tuberculosis-human immunodeficiency virus co-infected patients: a cross-sectional study in Uganda.

Authors:  Agnes Bwanika Naggirinya; Andrew Mujugira; David B Meya; Irene Andia Biraro; Ezekiel Mupere; William Worodria; Yukari C Manabe
Journal:  BMC Res Notes       Date:  2020-04-19

5.  Sub-clinical addison's disease.

Authors:  Manash P Baruah
Journal:  Indian J Endocrinol Metab       Date:  2012-12

6.  Adrenal reserve in acute exacerbation of non-cystic fibrosis bronchiectasis.

Authors:  Srinivas Rajagopala; Anantharaman Ramakrishnan; Anushree Chakraborty; Ganapathi Bantwal; Uma Devaraj; George D'Souza
Journal:  Indian J Med Res       Date:  2015-12       Impact factor: 2.375

7.  Multidrug-Resistant Tuberculosis and Its Association with Adrenal Insufficiency: Assessment with the Low-Dose ACTH Stimulation Test.

Authors:  René Rodríguez-Gutiérrez; Adrian Rendon; Maximiliano Barrera-Sánchez; Kevin Erick Gabriel Carlos-Reyna; Neri Alejandro Álvarez-Villalobos; Gloria González-Saldivar; José Gerardo González-González
Journal:  Int J Endocrinol       Date:  2016-02-23       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.